MD1223B1 - Application of S-methyl isothiouronium dimethyl phosphate as a va-so-con-stric-tor compound and pharmaceutical preparation on base thereof - Google Patents

Application of S-methyl isothiouronium dimethyl phosphate as a va-so-con-stric-tor compound and pharmaceutical preparation on base thereof

Info

Publication number
MD1223B1
MD1223B1 MD970201A MD970201A MD1223B1 MD 1223 B1 MD1223 B1 MD 1223B1 MD 970201 A MD970201 A MD 970201A MD 970201 A MD970201 A MD 970201A MD 1223 B1 MD1223 B1 MD 1223B1
Authority
MD
Moldova
Prior art keywords
dimethyl phosphate
stric
con
base
application
Prior art date
Application number
MD970201A
Other languages
Romanian (ro)
Other versions
MD1223C2 (en
Inventor
Victor GHICAVII
Victor Darciuc
Lev Mizrah
Original Assignee
Univ Nicolae Testemitanu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nicolae Testemitanu filed Critical Univ Nicolae Testemitanu
Priority to MD97-0201A priority Critical patent/MD1223C2/en
Publication of MD1223B1 publication Critical patent/MD1223B1/en
Publication of MD1223C2 publication Critical patent/MD1223C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to the pharmacology and can be used for treatment of different pathological affections, accompanied by vasodilation. The summary of the invention consists in the fact that in the capacity of a vasoconstrictor compound is proposed a thiourea derivative - S-methyl isothiouronuim dimethyl phosphate as well as The present compound possesses a vasoconstrictive action similar by the effect intensity to isoturone and phenylephrine hydrochloride, and the action period, correspondingly, being of 5 and
MD97-0201A 1997-07-15 1997-07-15 Application of S-methyl isothiouronium dimethyl phosphate as a vasoconstrictor compound and pharmaceutical preparation on base thereof MD1223C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MD97-0201A MD1223C2 (en) 1997-07-15 1997-07-15 Application of S-methyl isothiouronium dimethyl phosphate as a vasoconstrictor compound and pharmaceutical preparation on base thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MD97-0201A MD1223C2 (en) 1997-07-15 1997-07-15 Application of S-methyl isothiouronium dimethyl phosphate as a vasoconstrictor compound and pharmaceutical preparation on base thereof

Publications (2)

Publication Number Publication Date
MD1223B1 true MD1223B1 (en) 1999-05-31
MD1223C2 MD1223C2 (en) 2000-01-31

Family

ID=19739036

Family Applications (1)

Application Number Title Priority Date Filing Date
MD97-0201A MD1223C2 (en) 1997-07-15 1997-07-15 Application of S-methyl isothiouronium dimethyl phosphate as a vasoconstrictor compound and pharmaceutical preparation on base thereof

Country Status (1)

Country Link
MD (1) MD1223C2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2447G2 (en) * 2000-09-05 2005-12-31 Meditor Pharmaceuticals Ltd Pharmaceutical composition, use thereof and methods of treatment of cephalalgia, migraine, sickness and vomiting
MD2850G2 (en) * 2005-02-18 2006-07-31 Валентин ФРИПТУ Method of inducing the medicamental abortion

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD1431G2 (en) * 1998-01-16 2001-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Antihypotensive remedies
MD2228G2 (en) * 2003-01-21 2004-02-29 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова use of isothiouronic derivatives in the treatment and prophylaxis of intestinal atony
MD3644G2 (en) * 2008-03-17 2009-02-28 Рафаэль Баркан Preparation for algodismenorrhea treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2012333C1 (en) * 1989-05-12 1994-05-15 Государственный медицинский университет им.Н.Тестемицану Республики Молдова Method of shock treatment
MD586C2 (en) * 1995-05-25 1997-03-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Remedy antihypotensif "Difetur"

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2447G2 (en) * 2000-09-05 2005-12-31 Meditor Pharmaceuticals Ltd Pharmaceutical composition, use thereof and methods of treatment of cephalalgia, migraine, sickness and vomiting
MD2850G2 (en) * 2005-02-18 2006-07-31 Валентин ФРИПТУ Method of inducing the medicamental abortion

Also Published As

Publication number Publication date
MD1223C2 (en) 2000-01-31

Similar Documents

Publication Publication Date Title
NO20004803L (en) Smilagening and anzurogenin for the treatment of Alzheimer's disease
BR9916307A (en) Quinoline derivatives
NO20025450D0 (en) New pharmaceutical composition
FI961809A (en) Novel (R) -5-carbamoyl-8-fluoro-3-N, N-disubstituted amino 3,4-dihydro-2H-1-benzopyrans
NO971889L (en) Compounds and compositions for delivery of active agents
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
ATE218854T1 (en) TREATMENT OF CARDIAC ARTHRY DISORDERS BY INHIBITING A MULTIFUNCTIONAL CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE
HUP0301349A2 (en) Formulations for il-11
CA2336833A1 (en) Remedy with antidepressant effects
MX9706647A (en) Pharmaceutical compositions comprising monoamine oxidase b inhibitors.
DK0460062T3 (en) Huperzin A analogues
HUP0004544A2 (en) Process for preparation pharmaceutical composition combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders
BG105256A (en) Muscarinic agonists and antagonists
MD1223B1 (en) Application of S-methyl isothiouronium dimethyl phosphate as a va-so-con-stric-tor compound and pharmaceutical preparation on base thereof
BR9611642A (en) Pharmaceutical composition compounds and process for the preparation of compounds
HUP0202729A2 (en) Compositions for parenteral use of estramustine phosphate and amino acids
ATE120190T1 (en) 5-FLUORINE-2,4,6-PYRIMIDINTHIAMINE DERIVATIVES TO PREVENT HAIR LOSS.
MXPA03011502A (en) Substituted aminoalcohols useful in treatment of alzheimer's disease.
GB2306885B (en) Supersaturated Pharmaceutical Compositions
DE69717253D1 (en) captopril
TR199900141T2 (en) Formulation for the treatment and/or prophylaxis of dementia.
BG104162A (en) Pharmaceutical composition active in the reduction of the mcp-1 protein production
RU96124022A (en) METHOD FOR TREATING RED FLAT EXCHANGE OF MUSCULA OF THE ORAL CAVITY
HUP9802142A2 (en) Use of na+/h+ -ion-exchange inhibitors for producing pharmaceutical compositions for treating and profilacting diseases of the central nerve system
BR9908155A (en) Compound, pharmaceutical composition, use of the compound, and, process to intensify cognition in a subject suffering from decreased cognition

Legal Events

Date Code Title Description
PD99 Pending application